cancerbiology.dfci.harvard.edu
Cancer Biology Labs
http://cancerbiology.dfci.harvard.edu/laboratories.php
Department of Cancer Biology. Rameen Beroukhim, M.D., Ph.D. Stephen C. Blacklow, M.D., Ph.D. Nika N. Danial, Ph.D. Michael J. Eck, M.D., Ph.D. Ulrike S. Eggert, Ph.D. Suzanne Gaudet, Ph.D. Alexander Gimelbrant, Ph.D. Nathanael S. Gray, Ph.D. J Dirk Iglehart, M.D. David M. Livingston, M.D. Qiufu Ma, Ph.D. Jarrod Marto, Ph.D. Yoshihiro Nakatani, Ph.D. Pere Puigserver, Ph.D. Thomas M. Roberts, Ph.D., Co-Chair. Rosalind Segal, M.D., Ph.D. William M. Shih, Ph.D. Peter Sicinski, M.D., Ph.D. Marc Vidal, Ph.D.
symposium.nccr-chembio.ch
Speakers - International Symposium on Chemical Biology
http://symposium.nccr-chembio.ch/speakers
Speakers - International Symposium on Chemical Biology. Activity-based proteomics applications for protein and ligand discovery. The Skaggs Institute for Chemical Biology, Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California/ USA. Adam E. Cohen. Neuronal disease modeling with all-optical electrophysiology. Departments of Chemistry, Chemistry Biology and of Physics, Harvard University, Cambridge MA/USA. Moving chemical information through the plasma membrane. Stanford - ...
danafarberplga.org
Drug Development : Dana Farber PLGA
http://danafarberplga.org/drug-development
Clinical Trials & Tumor Banking. Nathanael Gray, PhD. In addition to understanding the causes of cancer, we are also focused on developing small molecules to inhibit aberrant intracellular signaling pathways. Nathanael Gray, PhD. Neal Rosen, MD, PhD. Our investigators are collaborating with Neal Rosen, MD, PhD. Nathalie Agar, PhD. In addition to drug development, it is also important to find out if the small molecules can pass through the blood:brain barrier (BBB). The BBB acts like a physiological w...
danafarberplga.org
Tumor Micro-environment : Dana Farber PLGA
http://danafarberplga.org/tumor-micro-environments
Clinical Trials & Tumor Banking. Rosalind Segal, MD, PhD. In order to develop novel therapies, research in the lab of Rosalind Segal, MD, PhD. Is aimed at understanding the biology of cerebellar pilocytic astrocytomas. Why do tumors that express the KIAA1549-BRAF fusion genes only occur in the cerebellum? And Charles Stiles, PhD. We are also using the slice culture assay to test preclinical compounds on their ability to impede tumor growth. Kim Wilkinson, PhD.